
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
4.7
127127 ratings
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
129 Listeners
325 Listeners
161 Listeners
862 Listeners
493 Listeners
31 Listeners
279 Listeners
87 Listeners
1,090 Listeners
61 Listeners
39 Listeners
185 Listeners
349 Listeners
426 Listeners
37 Listeners